Biotechnology stocks
1,443 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $266.14 | +0.45% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.50 | +0.27% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.69 | +0.39% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.14 | +0.01% |
| argenx SEENXTBR: ARGX | $65.85B | €882.20 | -2.20% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.01 | -1.42% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
| Natera, Inc.NasdaqGS: NTRA | $47.86B | $332.21 | +0.05% |
| Revolution Medicines, Inc.NasdaqGS: RVMD | $44.89B | $210.86 | +0.67% |
| BeOne Medicines AGNasdaqGS: ONC | $42.58B | $374.47 | +1.44% |
| Biogen Inc.NasdaqGS: BIIB | $32.03B | $217.06 | +0.13% |
| Celltrion, Inc.KOSE: A068270 | $31.82B | ₩192,300.00 | -4.33% |
| Alnylam Pharmaceuticals, Inc.NasdaqGS: ALNY | $31.61B | $236.75 | +0.22% |
| BioNTech SENasdaqGS: BNTX | $29.28B | $114.75 | -1.56% |
| Insmed IncorporatedNasdaqGS: INSM | $27.47B | $126.47 | +0.56% |
| Roivant Sciences Ltd.NasdaqGS: ROIV | $26.22B | $36.44 | +0.39% |
| Incyte CorporationNasdaqGS: INCY | $25.91B | $127.81 | +0.46% |
| Innovent Biologics, Inc.SEHK: 1801 | $22.74B | HK$102.40 | +9.17% |
| United Therapeutics CorporationNasdaqGS: UTHR | $22.01B | $513.12 | -1.51% |
| Genmab A/SCPSE: GMAB | $20.06B | Dkr2,114.00 | -1.72% |
| PharmaEssentia CorporationTWSE: 6446 | $18.22B | NT$1,400.00 | -6.67% |
| Swedish Orphan Biovitrum AB (publ)OM: SOBI | $16.87B | Skr454.20 | -1.26% |
| Ascendis Pharma A/SNasdaqGS: ASND | $16.63B | $253.29 | -0.60% |
| ALTEOGEN Inc.KOSDAQ: A196170 | $16.08B | ₩320,000.00 | +1.91% |
| BridgeBio Pharma, Inc.NasdaqGS: BBIO | $15.93B | $81.50 | -1.74% |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SEHK: 6990 | $15.85B | HK$520.50 | -3.52% |
| Neurocrine Biosciences, Inc.NasdaqGS: NBIX | $15.51B | $153.22 | +0.43% |
| Exelixis, Inc.NasdaqGS: EXEL | $13.40B | $54.08 | +0.72% |
| BioMarin Pharmaceutical Inc.NasdaqGS: BMRN | $12.91B | $66.70 | -1.45% |
| Arrowhead Pharmaceuticals, Inc.NasdaqGS: ARWR | $12.30B | $87.50 | +0.45% |
| Halozyme Therapeutics, Inc.NasdaqGS: HALO | $12.28B | $108.17 | +1.90% |
| Madrigal Pharmaceuticals, Inc.NasdaqGS: MDGL | $11.94B | $516.74 | -0.45% |
| ABIVAX Société AnonymeENXTPA: ABVX | $11.12B | €101.80 | -1.45% |
| Cytokinetics, IncorporatedNasdaqGS: CYTK | $10.68B | $76.84 | -0.44% |
| Akeso, Inc.SEHK: 9926 | $10.60B | HK$90.25 | -3.89% |
| Summit Therapeutics Inc.NasdaqGM: SMMT | $10.50B | $13.09 | -0.53% |
| Praxis Precision Medicines, Inc.NasdaqGS: PRAX | $10.49B | $381.99 | +1.64% |
| Krystal Biotech, Inc.NasdaqGS: KRYS | $10.26B | $346.61 | +0.01% |
| Apogee Therapeutics, Inc.NasdaqGM: APGE | $10.16B | $134.75 | 0.00% |
| Protagonist Therapeutics, Inc.NasdaqGM: PTGX | $9.99B | $154.33 | +0.01% |
| Kymera Therapeutics, Inc.NasdaqGM: KYMR | $9.96B | $119.95 | +0.13% |
| Ionis Pharmaceuticals, Inc.NasdaqGS: IONS | $9.93B | $61.19 | +2.39% |
| Spyre Therapeutics, Inc.NasdaqGS: SYRE | $9.39B | $105.72 | -0.72% |
| Vaxcyte, Inc.NasdaqGS: PCVX | $9.32B | $62.62 | +2.09% |
| Immunovant, Inc.NasdaqGS: IMVT | $9.16B | $44.25 | -0.27% |
| Twist Bioscience CorporationNasdaqGS: TWST | $9.13B | $145.09 | -0.34% |
| RemeGen Co., Ltd.SEHK: 9995 | $9.01B | HK$80.70 | -6.43% |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd.SEHK: 2315 | $8.37B | HK$69.00 | +11.65% |
| ImmunityBio, Inc.NasdaqGS: IBRX | $8.27B | $7.76 | -0.51% |
| Alkermes plcNasdaqGS: ALKS | $8.11B | $48.33 | +0.65% |
| TG Therapeutics, Inc.NasdaqCM: TGTX | $7.70B | $54.49 | +0.41% |
| Samsung Epis Holdings Co., Ltd.KOSE: A0126Z0 | $7.62B | ₩433,500.00 | +2.73% |
| Rhythm Pharmaceuticals, Inc.NasdaqGM: RYTM | $7.57B | $110.00 | +0.99% |
| Caris Life Sciences, Inc.NasdaqGS: CAI | $7.42B | $25.88 | -1.48% |
| Oruka Therapeutics, Inc.NasdaqCM: ABIO | $7.15B | $— | — |
| Oruka Therapeutics, Inc.NasdaqGM: ORKA | $7.15B | $107.90 | -0.06% |
| CG Oncology, Inc.NasdaqGS: CGON | $7.07B | $79.81 | +2.83% |
| Biocon LimitedNSEI: BIOCON | $7.03B | Rs415.55 | -0.35% |
| Grifols, S.A.BME: GRF | $6.97B | €9.87 | -0.42% |
| Scholar Rock Holding CorporationNasdaqGS: SRRK | $6.88B | $56.94 | +0.78% |
| Cogent Biosciences, Inc.NasdaqGS: COGT | $6.38B | $36.73 | +4.02% |
| Sunshine Guojian Pharmaceutical (Shanghai) Co., LtdSHSE: 688336 | $6.35B | CN¥47.65 | -1.55% |
| Mirum Pharmaceuticals, Inc.NasdaqGM: MIRM | $6.25B | $96.01 | -0.31% |
| Dianthus Therapeutics, Inc.NasdaqCM: DNTH | $6.21B | $110.70 | -0.36% |
| Travere Therapeutics, Inc.NasdaqGM: TVTX | $6.19B | $65.71 | +1.94% |
| Erasca, Inc.NasdaqGS: ERAS | $6.17B | $17.63 | +3.22% |
| Kiniksa Pharmaceuticals International, plcNasdaqGS: KNSA | $6.17B | $79.03 | +0.71% |
| Gan & Lee Pharmaceuticals.SHSE: 603087 | $6.06B | CN¥68.43 | -8.74% |
| Xenon Pharmaceuticals Inc.NasdaqGM: XENE | $5.88B | $60.77 | -2.53% |
| PTC Therapeutics, Inc.NasdaqGS: PTCT | $5.83B | $69.82 | -0.99% |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.SHSE: 603392 | $5.75B | CN¥30.59 | +1.63% |
| CRISPR Therapeutics AGNasdaqGM: CRSP | $5.75B | $59.48 | -0.03% |
| 3SBio Inc.SEHK: 1530 | $5.67B | HK$17.83 | +8.06% |
| ACADIA Pharmaceuticals Inc.NasdaqGS: ACAD | $5.08B | $30.00 | +1.69% |
| Suzhou Zelgen Biopharmaceuticals Co., Ltd.SHSE: 688266 | $5.07B | CN¥128.71 | +6.90% |
| Chongqing Zhifei Biological Products Co., Ltd.SZSE: 300122 | $4.95B | CN¥13.90 | +6.43% |
| Shanghai Junshi Biosciences Co., Ltd.SEHK: 1877 | $4.90B | HK$19.11 | -2.20% |
| Dyne Therapeutics, Inc.NasdaqGS: DYN | $4.87B | $26.10 | +0.46% |
| Parabilis Medicines, Inc.NasdaqGS: PBLS | $4.86B | $38.90 | -1.17% |
| Shanghai Henlius Biotech, Inc.SEHK: 2696 | $4.76B | HK$68.60 | +1.93% |
| Shanghai RAAS Blood Products Co., Ltd.SZSE: 002252 | $4.73B | CN¥4.82 | -2.82% |
| Celcuity Inc.NasdaqCM: CELC | $4.58B | $93.05 | -0.51% |
| Relay Therapeutics, Inc.NasdaqGM: RLAY | $4.26B | $19.65 | +1.08% |
| Legend Biotech CorporationNasdaqGS: LEGN | $4.23B | $22.00 | +0.82% |
| Imeik Technology Development Co.,Ltd.SZSE: 300896 | $4.14B | CN¥92.36 | -4.90% |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd.SHSE: 688192 | $4.08B | CN¥59.00 | -3.14% |
| Tango Therapeutics, Inc.NasdaqGM: TNGX | $4.03B | $23.88 | +1.57% |
| Denali Therapeutics Inc.NasdaqGS: DNLI | $3.98B | $24.92 | -0.12% |
| Viking Therapeutics, Inc.NasdaqCM: VKTX | $3.95B | $33.85 | -0.12% |
| Arcus Biosciences, Inc.NYSE: RCUS | $3.86B | $30.34 | +2.78% |
| Walvax Biotechnology Co., Ltd.SZSE: 300142 | $3.83B | CN¥16.10 | +21.23% |
| IDEAYA Biosciences, Inc.NasdaqGS: IDYA | $3.83B | $39.02 | -1.64% |
| Telix Pharmaceuticals LimitedASX: TLX | $3.80B | AU$15.62 | -6.63% |
| InnoCare Pharma LimitedSEHK: 9969 | $3.78B | HK$14.27 | -4.48% |
| Xiamen Amoytop Biotech Co., Ltd.SHSE: 688278 | $3.76B | CN¥61.88 | +1.78% |
| Iovance Biotherapeutics, Inc.NasdaqGM: IOVA | $3.76B | $8.25 | -0.48% |
| Hualan Biological Engineering Inc.SZSE: 002007 | $3.58B | CN¥13.17 | -0.75% |
| Beijing Tiantan Biological Products Co., Ltd.SHSE: 600161 | $3.57B | CN¥12.15 | -3.11% |
| Zealand Pharma A/SCPSE: ZEAL | $3.48B | Dkr317.00 | -1.31% |